Bengt von Mentzer

961 total citations · 1 hit paper
17 papers, 757 citations indexed

About

Bengt von Mentzer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Bengt von Mentzer has authored 17 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 4 papers in Psychiatry and Mental health. Recurrent topics in Bengt von Mentzer's work include Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Bengt von Mentzer is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Bengt von Mentzer collaborates with scholars based in Sweden, United Kingdom and United States. Bengt von Mentzer's co-authors include Martin Steinhoff, Charalabos Pothoulakis, Pierangelo Geppetti, Nigel W. Bunnett, Erik Lindström, Georges Vauquelin, Ingela Ahlstedt, Ingrid Påhlman, Ralf Schmidt and Edward Roberts and has published in prestigious journals such as Physiological Reviews, Biochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Bengt von Mentzer

17 papers receiving 747 citations

Hit Papers

Tachykinins and Their Rec... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bengt von Mentzer Sweden 10 376 341 147 82 62 17 757
M Dvořáková Czechia 19 171 0.5× 376 1.1× 139 0.9× 70 0.9× 118 1.9× 63 946
Maria Giuliana Vannucchi Italy 12 150 0.4× 226 0.7× 105 0.7× 67 0.8× 111 1.8× 13 722
R. Kage United States 13 479 1.3× 410 1.2× 120 0.8× 51 0.6× 43 0.7× 22 704
Joseph P. McGillis United States 15 438 1.2× 350 1.0× 362 2.5× 116 1.4× 50 0.8× 24 1.0k
Patrizia M. Germano United States 17 246 0.7× 221 0.6× 99 0.7× 33 0.4× 109 1.8× 36 695
J Cermák United States 22 209 0.6× 272 0.8× 262 1.8× 44 0.5× 41 0.7× 32 1.7k
Satoru Takahashi Japan 17 225 0.6× 382 1.1× 164 1.1× 85 1.0× 48 0.8× 95 1.1k
Robert A. Furlong United Kingdom 19 529 1.4× 679 2.0× 118 0.8× 278 3.4× 120 1.9× 32 1.5k
Nataša Kuštrimović Italy 16 247 0.7× 197 0.6× 134 0.9× 59 0.7× 42 0.7× 34 807
Alexander J. Davies United Kingdom 16 237 0.6× 174 0.5× 307 2.1× 31 0.4× 30 0.5× 31 768

Countries citing papers authored by Bengt von Mentzer

Since Specialization
Citations

This map shows the geographic impact of Bengt von Mentzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt von Mentzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt von Mentzer more than expected).

Fields of papers citing papers by Bengt von Mentzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt von Mentzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt von Mentzer. The network helps show where Bengt von Mentzer may publish in the future.

Co-authorship network of co-authors of Bengt von Mentzer

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt von Mentzer. A scholar is included among the top collaborators of Bengt von Mentzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt von Mentzer. Bengt von Mentzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bölcskei, Kata, et al.. (2023). Novel peptide calcitonin gene-related peptide antagonists for migraine therapy. Journal of Pharmacy and Pharmacology. 75(12). 1581–1589. 3 indexed citations
2.
Mentzer, Bengt von, Andrew F. Russo, Zhongming Zhang, et al.. (2020). A CGRP receptor antagonist peptide formulated for nasal administration to treat migraine. Journal of Pharmacy and Pharmacology. 72(10). 1352–1360. 12 indexed citations
3.
Conibear, Alexandra E., Junaid Asghar, R. W. Hill, et al.. (2019). A Novel G Protein–Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain. Journal of Pharmacology and Experimental Therapeutics. 372(2). 224–236. 48 indexed citations
4.
Kendall, David A., et al.. (2017). Biased Agonism at Cannabinoid CB 1 and δ-Opioid Receptors; Therapeutic Potential. Neuropeptides. 65. 131–131. 1 indexed citations
5.
Steinhoff, Martin, Bengt von Mentzer, Pierangelo Geppetti, Charalabos Pothoulakis, & Nigel W. Bunnett. (2014). Tachykinins and Their Receptors: Contributions to Physiological Control and the Mechanisms of Disease. Physiological Reviews. 94(1). 265–301. 466 indexed citations breakdown →
6.
Gillies, Stuart, K. Haddley, Gregory M. Jacobson, et al.. (2010). Distinct Gene Expression Profiles Directed by the Isoforms of the Transcription Factor Neuron-Restrictive Silencer Factor in Human SK-N-AS Neuroblastoma Cells. Journal of Molecular Neuroscience. 44(2). 77–90. 9 indexed citations
7.
Ahlstedt, Ingela, Arne Svensson, Martin Billger, et al.. (2009). Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3. Biochemical Pharmacology. 77(9). 1522–1530. 33 indexed citations
8.
Ahlstedt, Ingela, John W. Smith, Chris Perrey, et al.. (2008). Occurrence and pharmacological characterization of four human tachykinin NK2 receptor variants. Biochemical Pharmacology. 76(4). 476–481. 4 indexed citations
9.
Brusberg, Mikael, Elin Sand, Håkan Larsson, et al.. (2008). Role of tachykinin NK1 and NK2 receptors in colonic sensitivity and stress-induced defecation in gerbils. European Journal of Pharmacology. 582(1-3). 123–131. 8 indexed citations
10.
Vauquelin, Georges & Bengt von Mentzer. (2008). G Protein-Coupled Receptors: Molecular Pharmacology from Academic Concept to Pharmaceutical Research. Medical Entomology and Zoology. 7 indexed citations
11.
Lindström, Erik, et al.. (2007). Neurokinin 1 Receptor Antagonists: Correlation between in Vitro Receptor Interaction and in Vivo Efficacy. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1286–1293. 64 indexed citations
12.
Sundqvist, Monika, Rolf Adolfsson, Ingela Ahlstedt, et al.. (2007). Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. European Journal of Pharmacology. 577(1-3). 78–86. 10 indexed citations
13.
Vauquelin, Georges & Bengt von Mentzer. (2007). G Protein‐Coupled Receptors. 12 indexed citations
14.
Mentzer, Bengt von, et al.. (2006). Functional CRF receptors in BON cells stimulate serotonin release. Biochemical Pharmacology. 73(6). 805–813. 22 indexed citations
15.
Ahlstedt, Ingela, Erik Lindström, Arne Svensson, et al.. (2006). Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors. Biochemical Pharmacology. 73(2). 259–269. 15 indexed citations
16.
Nodin, Christina, Georges Vauquelin, & Bengt von Mentzer. (2005). Cys2,7EtαCGRP is a potent agonist for CGRP1 receptors in SK-N-MC cells. Biochemical Pharmacology. 69(8). 1235–1240. 5 indexed citations
17.
Schmidt, Ralf, et al.. (2001). Turn Structures in CGRP C-Terminal Analogues Promote Stable Arrangements of Key Residue Side Chains. Biochemistry. 40(28). 8317–8325. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026